Board of Directors


Rx&D has an effective and engaged Board of Directors that enables member companies to achieve common objectives.

Executive Committee/Officers

John Helou, President, Pfizer Canada Inc.
First Vice-Chair
Michael Tremblay, President, Astellas Pharma Canada, Inc.
Second Vice Chair
Elaine Campbell, President & CEO, AstraZeneca Canada Inc.
Frédéric Fasano, Chief Executive Officer, Servier Canada Inc.
Member at Large
Vince Lamanna, President, Novo Nordisk Canada Inc.
Immediate Past Chair
Mark Lievonen, President, Sanofi Pasteur Limited
Chris Halyk, President, Janssen Inc.
Ex-OfficioRonnie Miller, President & CEO, Hoffmann-La Roche Limited 
President Russell Williams, Canada’s Research-Based Pharmaceutical Companies (Rx&D)


Mark Beaudet, President & CEO, Paladin Labs Inc.

Patrick Cashman, President and General Manager, Lundbeck Canada Inc.

Mike Egli, President & CEO, Takeda Canada Inc.

Gilles Gagnon, President & CEO, Ceapro Inc.

Ed Gudaitis, General Manager, Gilead Sciences Canada Inc.

Chirfi Guindo, President & Managing Director, Merck Canada Inc.

Helen Jordan, General Manager and Vice-President, Amgen Canada Inc.

Vince Lamanna, President, Novo Nordisk Canada Inc.

Craig Landau, President & CEO, Purdue Pharma

Stéphane Lassignardie, General Manager, AbbVie Corporation 

Christian Lauterbach, President & CEO, Bayer Inc.

Jean-François Leprince, President, GLyPharma Therapeutique Inc.  

Paul Lirette, President, GlaxoSmithKline Inc.

Tim Maloney, President, Novartis Pharmaceuticals Canada Inc.

Lisa Matar, President & General Manager, Eli Lilly Canada inc.

Allison Rosental, General Manager, Otsuka Canada Pharmaceutical Inc. (OCPI)

Oliver Technow, President & General Manager, Eisai Limited

Revised: November 21, 2014